Keros Therapeutics, Inc. (KROS)
Latest KROS Insider Trades
About Keros Therapeutics, Inc. (KROS)
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
- LEXINGTON, MA
- 92
- 2020
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 3,000 | $31K |
| Open-market sale | 8 | 18,253 | $191K |
| Grant or award | 10 | 86,956 |
KROS Insider Transactions (Form 4)
2040 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jasbir Seehra - Officer | Grant or award | Employee Stock Option (right to buy) | 62,500 |
Recent KROS Form 8-K Filings
5Recent KROS Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Newton Charles W. | Director | 551 | $6K | View on EDGAR | |
| - | - |
KROS Insider Trading - FAQ
What is the latest insider trade for KROS?
Keros Therapeutics, Inc. (KROS) had 16 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for KROS runs to 40 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KROS stock?
3 insider purchases of KROS were filed in the last 90 days, totaling $31K.
How many insiders are selling KROS stock?
8 insider sales of KROS were filed in the last 90 days, totaling $191K.
Where can I see KROS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KROS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KROS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KROS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Annita Tanini view on EDGAR
- - Lorena Raquel Lerner view on EDGAR
- - Esther Cho view on EDGAR
- - Charles W. Newton view on EDGAR
- - Jean Jacques Bienaime view on EDGAR
- - Jean Jacques Bienaime view on EDGAR
- - Anne Prener view on EDGAR
- - Jean Jacques Bienaime view on EDGAR
- - Charles W. Newton view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where KROS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KROS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
